Despite posting record earnings in its theme parks division, The Walt Disney Company saw its shares tumble sharply following its Q1 FY2026 report, as investor concerns over streaming profitability and rising costs overshadowed the success of its Experiences business.
Despite its leadership in high-demand defense sectors like drones and hypersonics, Kratos Defense & Security's shares face sustained pressure as investors question its sky-high valuation and cash flow.
Devon Energy's stock sees modest gains while Coterra dips following their $58 billion merger announcement, a deal that will relocate Devon's headquarters from Oklahoma City to Houston by 2026.
In a stark episode of his show, personal finance expert Dave Ramsey labeled a husband's control over family finances as '100% abusive.' The case highlights how economic manipulation traps victims, a pattern experts say underpins nearly all domestic violence.
NuScale Power's stock has surged over 640% since early 2024, fueled by investor optimism around its small modular reactor technology. While the potential is vast, analysts caution the road ahead remains fraught with financial and regulatory challenges.
NXP Semiconductors (NXPI) reports Q4 2025 earnings after the bell today. With Wall Street eyeing modest growth, the chipmaker's performance in its core automotive segment—nearly 60% of revenue—will be the key test for its 2026 trajectory.
Stephon Dubose has pleaded guilty to the 2023 murder of Angela Risi, a graduate dance student at Duke University, and the attempted murder of her roommate. The attack was motivated by Risi's refusal to commit to an exclusive relationship, prosecutors said.
With U.S. sanctions easing, Chevron is accelerating its expansion in Venezuela, aiming to boost production by 50% and secure discounted heavy crude for its refineries, a strategic move to bolster cash flow and shareholder returns amid volatile earnings.
A synchronized selloff on January 30, 2026, saw Bitcoin and key industrial metals like copper plunge together, underscoring Bitcoin's evolving role as a barometer for global economic sentiment rather than a digital safe haven.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
A speculative frenzy fueled by geopolitical tensions and dollar fears met its abrupt end last Friday, triggering the worst single-day plunge in silver since 1980 and a massive gold sell-off. Analysts point to leveraged bets and a shifting Fed outlook as key catalysts for the historic crash.
Amid a flurry of bank mergers and acquisitions reshaping Texas, San Antonio-based Frost Bank is doubling down on its organic growth strategy. CEO Phil Green asserts the bank has "zero interest" in M&A, positioning itself to win customers dislocated by industry upheaval.
New federal data reveals a significant year-over-year jump in energy costs for November, with natural gas prices soaring and electricity rates climbing, squeezing household budgets amid fluctuating demand and generation patterns.
German biotech firm AMSilk partners with Italian mill Pure Denim to launch a new category of high-performance, sustainable denim infused with lab-grown spider silk proteins, targeting the luxury market with enhanced comfort and eco-credentials.
A retrospective analysis reveals the staggering returns from Warren Buffett's key 2016 investments, with a stake in Apple vastly outperforming his own conglomerate and the broader S&P 500 index over ten years.
The Walt Disney Company's latest quarterly results surpassed Wall Street's modest expectations, yet its stock failed to rally. While its Experiences division continues to be a profit powerhouse and streaming turns a corner, broader challenges and a shrinking 'beat' margin leave investors watching for a catalyst.
Despite recent turbulence, Boeing shares have climbed over 30% in the past year, outpacing the S&P 500. Analysts remain largely bullish, citing a record backlog and strategic moves, though some caution lingers over execution and supply chain hurdles.
Despite a challenging year marked by a steep sell-off after disappointing Medicare rate updates, analysts are showing tentative signs of increased confidence in the managed care giant, though a consensus 'Hold' rating prevails.
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.
Shares of USA Rare Earth (NASDAQ: USAR) climbed over 6% Monday morning following reports of a proposed U.S. government initiative, dubbed 'Project Vault,' aimed at securing a strategic reserve of critical minerals, including rare earths, to counter potential supply chain vulnerabilities.
